A discussion around this relationship and the effects of TP53 on breast cancer risk has been recently published17 but interestingly the strength of effect on breast cancer risk we report with RHOD is even stronger than that of a well-established target (rs78378222 at TP53) on breast cancer risk. Here, TP53 is linked to breast carcinoma.